# Recursion Pharmaceuticals funding: rounds and investors > Recursion Pharmaceuticals has raised $339M across 8 rounds since 2014. Investors include Felicis, Lux Capital and Menlo Ventures. Every round with its source. Source: https://millionrounds.com/company/recursion-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *Recursion Pharmaceuticals* 8 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. AI Biotech Healthcare Funding summary Updated 26 Oct 2026 **$339M** raised across 8 rounds since 2014, from 8 sources **$130K** Seed **$170K** Seed **$830K** Debt **$1.5M** Grant **$13M** Series A **$2.1M** Series A **$121M** Series C **$200M** Round - **Latest round:** Round, $200M Jun 2024 - **Step-up i:** 1.7× - **Investors:** 7 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2014 2016 2018 2020 2022 2024 **$130K** Seed **$170K** Seed **$830K** Debt **$13M** Series A **$2.1M** Series A **$121M** Series C **$200M** Round - **First round:** Seed, $130K - **Biggest round:** $200M - **Usual gap between rounds:** 19 months ## The rounds - **Jun 2024** Round **$200M** *4 new* *2 returning* [Menlo Ventures](https://millionrounds.com/fund/menlo-ventures) [Felicis](https://millionrounds.com/fund/felicis-ventures) [Lux Capital](https://millionrounds.com/fund/lux-capital) [NVIDIA](https://millionrounds.com/fund/nvidia) [Obvious Ventures](https://millionrounds.com/fund/obvious-ventures) [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) Source recorded - **Jul 2019** Series C **$121M** No investor was named in the report. Reported by Healthtechpulse SEC filing: $122M sold, first sale Feb 2019 - **Nov 2016** Series A **$2.1M** *1 new* [Felicis](https://millionrounds.com/fund/felicis-ventures) Reported by FinSMEs SEC filing: $15M sold, first sale Sept 2016 - **Oct 2016** Series A **$13M** *1 new* [Lux Capital](https://millionrounds.com/fund/lux-capital) Reported by FinSMEs SEC filing: $4.1M sold, first sale Sept 2016 - **Feb 2015** Grant **$1.5M** *1 new* [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) From a historical funding record SEC filing: $830K sold, first sale Feb 2015 - **Feb 2015** Debt **$830K** No investor was named in the report. From a historical funding record SEC filing: $830K sold, first sale Feb 2015 - **Aug 2014** Seed **$170K** No investor was named in the report. From a historical funding record - **Jan 2014** Seed **$130K** No investor was named in the report. From a historical funding record SEC filing: $80K sold, first sale Mar 2014 ## Founders and team From Recursion Pharmaceuticals's own website and the SEC filings it signed: 5 on the team. - **Ben Taylor** Chief Financial Officer & President Recursion UK - **Erica Fox** Chief People and Impact Officer - **Ryan Kelly** Chief Communications Officer - **Christopher C. Gibson** Executive Officer, Director, Promoter i - **Michael Martin Secora** Executive Officer, Promoter i On the board, as filed i *Blake C. Borgeson* *Dean C. Li* *R. Martin Chavez* *Robert C. Hershberg* *Terry-Ann C. Burrell* *Zachary C. Bogue* *Zavain C. Dar* ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Seed** 2014 **Seed** 2014 **Debt** 2015 **Grant** 2015 **Series A** 2016 **Series A** 2016 **Series C** 2019 **Round** 2024 [Felicis](https://millionrounds.com/fund/felicis-ventures) [Lux Capital](https://millionrounds.com/fund/lux-capital) [Menlo Ventures](https://millionrounds.com/fund/menlo-ventures) [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) [NVIDIA](https://millionrounds.com/fund/nvidia) [Obvious Ventures](https://millionrounds.com/fund/obvious-ventures) [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) ## Everyone who backed them [Felicis](https://millionrounds.com/fund/felicis-ventures) VC firm **2** rounds [Lux Capital](https://millionrounds.com/fund/lux-capital) VC firm **2** rounds [Menlo Ventures](https://millionrounds.com/fund/menlo-ventures) VC firm **1** round [National Institutes of Health](https://millionrounds.com/fund/national-institutes-of-health) Government **1** round [NVIDIA](https://millionrounds.com/fund/nvidia) Company **1** round [Obvious Ventures](https://millionrounds.com/fund/obvious-ventures) Accelerator **1** round [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=recursion-pharmaceuticals). ## Also claim to have backed them These 5 firms list Recursion Pharmaceuticals as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [CRV](https://millionrounds.com/fund/crv) VC firm Per its own site [Amplify Partners](https://millionrounds.com/fund/amplify-partners) VC firm Per its own site [Amino Collective](https://millionrounds.com/fund/amino-collective) VC firm Per its own site [Lingotto](https://millionrounds.com/fund/lingotto) Asset manager Per its own site [KQ Labs](https://millionrounds.com/fund/kq-labs) Accelerator Per its own site ## Quick answers about Recursion Pharmaceuticals ### Who invested in Recursion Pharmaceuticals? Recursion Pharmaceuticals's investors include Felicis, Lux Capital, Menlo Ventures, National Institutes of Health and NVIDIA, and 2 more on record. ### How much has Recursion Pharmaceuticals raised? Recursion Pharmaceuticals has raised $339M across 8 rounds since 2014. ### When did Recursion Pharmaceuticals last raise? Recursion Pharmaceuticals's most recent round was an Undisclosed round of $200M in Jun 2024. ### What was Recursion Pharmaceuticals's biggest round? Its most recent round, $200M in Jun 2024, is also its largest on record. ### Who backed Recursion Pharmaceuticals first? Recursion Pharmaceuticals's first round on record, in Feb 2015, was backed by National Institutes of Health. ### What stage is Recursion Pharmaceuticals at? Recursion Pharmaceuticals's latest named round is an Undisclosed round, in Jun 2024. ### Where is Recursion Pharmaceuticals based? Recursion Pharmaceuticals is based in the United States. ## Companies like Recursion Pharmaceuticals In the same sector, and raised in the last eighteen months. [**SpaceX** $42B · Oct 2026](https://millionrounds.com/company/spacex)[**xPay** $1.5M · Oct 2026](https://millionrounds.com/company/xpay)[**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**FORT Robotics** $39M · Oct 2026](https://millionrounds.com/company/fort-robotics)[**Albert Invent** $20M · Oct 2026](https://millionrounds.com/company/albert-invent)[**Pika** $216M · Oct 2026](https://millionrounds.com/company/pika) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app